GetTopicDetailResponse(id=38058082f9, topicName=GLP-1受體激動劑Rybelsus, introduction=GLP-1受體激動劑Rybelsus, content=null, image=null, comments=2, allHits=1212, url=https://h5.medsci.cn/topic?id=8082, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102322, tagList=[TagDto(tagId=102322, tagName=GLP-1受體激動劑Rybelsus)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1575334, encodeId=3db415e5334a3, content=<a href='/topic/show?id=38058082f9' target=_blank style='color:#2F92EE;'>#GLP-1受體激動劑Rybelsus#</a>, objectTitle=歐盟批準2型糖尿病藥物GLP-1受體激動劑Rybelsus, objectType=article, longId=191603, objectId=16ab191603bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16ab191603bc, replyNumber=0, likeNumber=93, createdTime=2020-04-08, rootId=0, userName=劉闊, userId=aa0116095386, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16ab191603bc, moduleTitle=歐盟批準2型糖尿病藥物GLP-1受體激動劑Rybelsus, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=16ab191603bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1575333, encodeId=bbe015e53331e, content=<a href='/topic/show?id=38058082f9' target=_blank style='color:#2F92EE;'>#GLP-1受體激動劑Rybelsus#</a>, objectTitle=歐洲藥品管理局的CHMP支持諾和諾德口服GLP-1受體激動劑Rybelsus，用于治療2型糖尿病, objectType=article, longId=187289, objectId=33a518e289cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a518e289cb, replyNumber=0, likeNumber=104, createdTime=2020-02-04, rootId=0, userName=劉闊, userId=aa0116095386, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a518e289cb, moduleTitle=歐洲藥品管理局的CHMP支持諾和諾德口服GLP-1受體激動劑Rybelsus，用于治療2型糖尿病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=33a518e289cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
